Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model (original) (raw)
Gottlieb, A., and Bos, J. Recombinantly engineered human proteins: transforming the treatment of psoriasis. Clin. Immunol.105, 105–116 (2002). ArticleCAS Google Scholar
Valdimarsson, H., Baker, B.S., Jonsdottir, I., Powles, A. & Fry, L. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol. Today16, 145–149 (1995). ArticleCAS Google Scholar
Christophers, E. The immunopathology of psoriasis. Int. Arch. Allergy Immunol.110, 199–206 (1996). ArticleCAS Google Scholar
Bos, J.D. & De Rie, M.A. The pathogenesis of psoriasis: immunological facts and speculations. Immunol. Today20, 40–46 (1999). ArticleCAS Google Scholar
Koo, J., Nguyen, Q. & Gambla, C. Advances in psoriasis therapy. Adv. Dermatol.12, 47–72 (1997). CASPubMed Google Scholar
Eedy, D.J., Burrows, D., Bridges, J.M. & Jones, F.G. Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ300, 908 (1990). ArticleCAS Google Scholar
Gardembas-Pain, M. et al. Psoriasis after allogeneic bone marrow transplantation. Arch. Dermatol.126, 1523 (1990). ArticleCAS Google Scholar
Lewis, H.M. et al. Restricted T-cell receptor V beta gene usage in the skin of patients with guttate and chronic plaque psoriasis. Br. J. Dermatol.129, 514–520 (1993). ArticleCAS Google Scholar
Leung, D.Y. et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J. Clin. Invest.96, 2106–2112 (1995). ArticleCAS Google Scholar
Wrone-Smith, T. & Nickoloff, B.J. Dermal injection of immunocytes induces psoriasis. J. Clin. Invest.98, 1878–1887 (1996). ArticleCAS Google Scholar
Nickoloff, B.J. & Wrone-Smith, T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am. J. Pathol.155, 145–58 (1999). ArticleCAS Google Scholar
Gilhar, A., David, M., Ullmann, Y., Berkutski, T. & Kalish, R.S. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice. J. Invest. Dermatol.109, 283–288 (1997). ArticleCAS Google Scholar
Schon, M.P. Animal models of psoriasis—what can we learn from them? J. Invest. Dermatol.112, 405–410 (1999). ArticleCAS Google Scholar
Li, A.G., Wang, D., Feng, X.H. & Wang, X.J. Latent TGFβ1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J.23, 1770–1781 (2004). ArticleCAS Google Scholar
Cook, P.W. et al. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J. Clin. Invest.100, 2286–2294 (1997). ArticleCAS Google Scholar
Xia, Y.P. et al. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood102, 161–168 (2003). ArticleCAS Google Scholar
Blumberg, H. et al. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell104, 9–19 (2001). ArticleCAS Google Scholar
Leonard, W.J. & O'Shea, J.J. Jaks and STATs: biological implications. Annu. Rev. Immunol.16, 293–322 (1998). ArticleCAS Google Scholar
Levy, D.E. & Darnell, J.E., Jr. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol.3 (9), 651–662 (2002). ArticleCAS Google Scholar
Hirano, T., Ishihara, K. & Hibi, M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene19, 2548–2456 (2000). ArticleCAS Google Scholar
Turkson, J. & Jove, R. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene19, 6613–6626 (2000). ArticleCAS Google Scholar
Sano, S. et al. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J.18, 4657–4668 (1999). ArticleCAS Google Scholar
Sano, S., Takeda, J., Yoshikawa, K. & Itami, S. Tissue regeneration: hair follicle as a model. J. Investig. Dermatol. Symp. Proc.6, 43–48 (2001). ArticleCAS Google Scholar
Takeda, J., Sano, S., Tarutani, M., Umeda, J. & Kondoh, G. Conditional gene targeting and its application in the skin. J. Dermatol. Sci.23, 147–54 (2000). ArticleCAS Google Scholar
Hertle, M.D., Kubler, M.D., Leigh, I.M. & Watt, F.M. Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J. Clin. Invest.89, 1892–1901 (1992). ArticleCAS Google Scholar
Ortonne, J.P. Aetiology and pathogenesis of psoriasis. Br. J. Dermatol.135 Suppl 49, 1–5 (1996). Article Google Scholar
Piepkorn, M., Pittelkow, M.R. & Cook, P.W. Autocrine regulation of keratinocytes: the emerging role of heparin-binding, epidermal growth factor-related growth factors. J. Invest. Dermatol.111, 715–721 (1998). ArticleCAS Google Scholar
Murillas, R. et al. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure. EMBO J.14, 5216–5223 (1995). ArticleCAS Google Scholar
Chan, K.S. et al. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res.64, 2382–2389 (2004). ArticleCAS Google Scholar
Chan, K.S. et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J. Clin. Invest.114, 720–728 (2004). ArticleCAS Google Scholar
Thewes, M., Stadler, R., Korge, B. & Mischke, D. Normal psoriatic epidermis expression of hyperproliferation-associated keratins. Arch. Dermatol. Res.283, 465–471 (1991). ArticleCAS Google Scholar
Ghadially, R., Reed, J.T. & Elias, P.M. Stratum corneum structure and function correlates with phenotype in psoriasis. J. Invest. Dermatol.107, 558–564 (1996). ArticleCAS Google Scholar
Detmar, M. et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med.180, 1141–1146 (1994). ArticleCAS Google Scholar
Leong, P.L. et al. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc. Natl. Acad. Sci. USA100, 4138–4143 (2003). ArticleCAS Google Scholar
McKenzie, R.C. & Sabin, E. Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis. Exp. Dermatol.12, 337–345 (2003). ArticleCAS Google Scholar
Griffiths, C.E., Voorhees, J.J. & Nickoloff, B.J. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J. Am. Acad. Dermatol.20, 617–629 (1989). ArticleCAS Google Scholar
Caldenhoven, E. et al. Activation of the STAT3/acute phase response factor transcription factor by interleukin-5. J. Biol. Chem.270, 25778–25784 (1995). ArticleCAS Google Scholar
Lebwohl, M. et al. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N. Engl. J. Med.349, 2004–2013 (2003). ArticleCAS Google Scholar
Krueger, J.G. The immunologic basis for the treatment of psoriasis with new biologic agents. J. Am. Acad. Dermatol.46, 1–23 (2002). Article Google Scholar
Lew, W. et al. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and “Type 1” inflammatory gene expression. Trends Immunol.25, 295–305 (2004). ArticleCAS Google Scholar
Baker, B.S., Powles, A.V., Valdimarsson, H., & Fry, L. An altered response by psoriatic keratinocytes to gamma interferon. Scand J. Immunol.28, 735–740 (1988). ArticleCAS Google Scholar
Nickoloff, B.J., Mitra, R.S., Elder, J.T., Fisher, G.J., & Voorhees, J.J. Decreased growth inhibition by recombinant γ interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions. Br. J. Dermatol.121, 161–174 (1989). ArticleCAS Google Scholar
Sato, T., Selleri, C., Young, N.S., & Maciejewski, J.P. Inhibition of interferon regulatory factor-1 expression results in predominance of cell growth stimulatory effects of interferon-γ due to phosphorylation of Stat1 and Stat3. Blood90, 4749–4758 (1997). CASPubMed Google Scholar
Qing, Y. & Stark, G.R. Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J. Biol. Chem.279, 41679–41685 (2004). ArticleCAS Google Scholar